VanEck Associates’s Artivion AORT Stock Holding History
Bought
Maintained
Sold
Other funds holding AORT
NAMI
JIC
OAM
PA
CCA
VanEck Associates's AORT Position: Q2 2026 in Review
VanEck Associates increased its Artivion (AORT) stake by 66% in Q2 2026, buying an estimated $119K and bringing the position to 10,749 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.
VanEck Associates first reported a position in AORT in Q2 2025 and has held it in 5 quarters since. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.
- VanEck Associates held 10,749 shares of Artivion worth $242K as of Q2 2026.
- VanEck Associates bought 4,269 Artivion shares in Q2 2026, an estimated $119K.
- Artivion made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1287 holding.
- VanEck Associates first reported a position in Artivion in Q2 2025 and has held it in 5 quarters since.
- 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.